炎症性肠病患者中抗肿瘤坏死因子治疗诱发的银屑病 - Suppr | 超能文献

Psoriasis induced by anti-tumour necrosis factor therapy in patients with inflammatory bowel disease.

作者信息

Salgueiro Paulo, Lago Paula, Pedroto Isabel

出版信息

J Crohns Colitis. 2013 Sep;7(8):e325-6. doi: 10.1016/j.crohns.2013.01.003. Epub 2013 Jan 22.

DOI:10.1016/j.crohns.2013.01.003

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Psoriasis induced by anti-tumour necrosis factor therapy in patients with inflammatory bowel disease.炎症性肠病患者中抗肿瘤坏死因子治疗诱发的银屑病

J Crohns Colitis. 2013 Sep;7(8):e325-6. doi: 10.1016/j.crohns.2013.01.003. Epub 2013 Jan 22.

2

Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: a report of 21 cases.抗 TNF 药物诱导炎症性肠病患者发生银屑病：21 例报告。

J Crohns Colitis. 2012 Jun;6(5):518-23. doi: 10.1016/j.crohns.2011.10.007. Epub 2011 Nov 13.

3

Weight gain and tumour necrosis factor-alpha inhibitors in patients with psoriasis.银屑病患者的体重增加与肿瘤坏死因子-α抑制剂。

Australas J Dermatol. 2013 Nov;54(4):259-63. doi: 10.1111/ajd.12044.

4

Infliximab-associated psoriasis in children with Crohn's disease may require withdrawal of anti-tumor necrosis factor therapy.克罗恩病患儿中与英夫利昔单抗相关的银屑病可能需要停用抗肿瘤坏死因子治疗。

Inflamm Bowel Dis. 2013 Apr;19(5):E75-7. doi: 10.1097/MIB.0b013e3182802c93.

5

The association of psoriasiform rash with anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease: a single academic center case series.炎症性肠病患者接受抗肿瘤坏死因子（anti-TNF）治疗后出现银屑病样皮疹：单中心病例系列研究。

J Crohns Colitis. 2014 Jun;8(6):480-8. doi: 10.1016/j.crohns.2013.10.013. Epub 2013 Nov 21.

6

Tuberculosis in anti-TNF-α treated patients remains a problem in countries with an intermediate incidence: analysis of 25 patients matched with a control population.抗 TNF-α 治疗患者中的结核病仍然是发病率中等国家的一个问题：25 例患者与对照人群匹配分析。

J Crohns Colitis. 2013 Nov;7(10):e486-92. doi: 10.1016/j.crohns.2013.03.004. Epub 2013 Apr 11.

7

Dermatological adverse reactions during anti-TNF treatments: focus on inflammatory bowel disease.抗 TNF 治疗中的皮肤不良反应：重点关注炎症性肠病。

J Crohns Colitis. 2013 Nov;7(10):769-79. doi: 10.1016/j.crohns.2013.01.009. Epub 2013 Mar 1.

8

Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature.炎症性肠病患者接受肿瘤坏死因子拮抗剂治疗后出现银屑病：一项新的系列研究及对文献中 120 例病例的回顾。

Aliment Pharmacol Ther. 2011 Dec;34(11-12):1318-27. doi: 10.1111/j.1365-2036.2011.04866.x. Epub 2011 Sep 29.

9

Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience.炎症性肠病抗TNF治疗皮肤并发症的累积发病率、危险因素及转归：14年经验

Am J Gastroenterol. 2015 Aug;110(8):1186-96. doi: 10.1038/ajg.2015.205. Epub 2015 Jul 21.

10

Infliximab-induced psoriasis in treatment of Crohn's disease-associated ankylosing spondylitis: case report and review of 142 cases.英夫利昔单抗治疗克罗恩病相关性强直性脊柱炎诱发银屑病：病例报告及142例病例回顾

J Drugs Dermatol. 2013 Aug;12(8):939-43.

引用本文的文献

1

Incidence of and Risk Factors for Paradoxical Psoriasis or Psoriasiform Lesions in Inflammatory Bowel Disease Patients Receiving Anti-TNF Therapy: Systematic Review With Meta-Analysis.接受 TNF 治疗的炎症性肠病患者发生矛盾性银屑病或银屑病样病变的发生率及危险因素：系统评价和荟萃分析。

Front Immunol. 2022 Mar 1;13:847160. doi: 10.3389/fimmu.2022.847160. eCollection 2022.

2

Impact of immune-mediated diseases in inflammatory bowel disease and implications in therapeutic approach.免疫介导性疾病对炎症性肠病的影响及其在治疗方法中的意义。

Sci Rep. 2020 Jul 1;10(1):10731. doi: 10.1038/s41598-020-67710-2.